Loading Events

Sex and Gender Differences in Obesity: Why It Matters for Women’s Obesity Care

September 29, 2026 @ 1:00 pm - 2:00 pm EDT

Obesity, defined as an excessive or abnormal accumulation of body fat, is a complex chronic disease. Obesity results from both internal and external factors that impact metabolic, physiologic, and psychological health. Obesity can be influenced by a combination of factors including biological sex, genetics, psychology, medical conditions, medications, environment, and socioeconomics. Due to the long-term and recurring nature of the disease, obesity is associated with increased health care costs, reduced quality of life, disability, and even early death.

While in the United States the prevalence of obesity among men and women is almost equivalent, the prevalence of severe (Class III) obesity is higher in women (12.1%) than men (6.7%). Further, there are reported sex and gender differences in the biological, physiological, behavioral, sociocultural, and psychological mechanisms of obesity. There are also differences in comorbidities, treatment responses, and health outcomes.

SWHR will host a virtual public forum to discuss the complex role of sex and gender in obesity. This event will educate health care providers and researchers on how biological, behavioral, and sociocultural factors influence obesity management and treatment outcomes.

Register Now

Details

Organizer

Goals

  • Examine sex as a biological variable in obesity
  • Analyze interactions between sex and gender and socioeconomic, psychosocial, and environmental determinants of obesity risk
  • Review sex and gender differences in obesity treatment and outcomes, with key considerations for clinical care
  • Discuss obesity prevention and treatment challenges disproportionately affecting women and the need for comprehensive, equitable obesity care for women

Are you interested in seeing more of this type of educational programming on women’s health from SWHR?

Donate Today

Panelists

Karen Reue, PhD

Professor of Human Genetics, Geffen School of Medicine, University of California, Los Angeles

Karen Reue, PhD

Professor of Human Genetics, Geffen School of Medicine, University of California, Los Angeles

Karen Reue, PhD, is Professor of Human Genetics in the Geffen School of Medicine, University of California, Los Angeles and director of an National Institutes of Health (NIH) Scientific Center of Research Excellence on Sex Differences in Cardiometabolic Health and Disease. The Reue laboratory is interested in the identification of genes, pathways, and the role of sex in the development of cardiometabolic diseases including obesity, fatty liver, and atherosclerosis. A key finding has been the importance of both gonadal hormones and sex chromosome gene dosage in sex-biased functions in adipose tissue and obesity, regulation of lipid metabolism, mitochondrial function, and drug adverse effects.

Tiffany Powell-Wiley, MD, MPH

Earl Stadtman Investigator, Chief of the Social Determinants of Obesity and Cardiovascular Risk Laboratory, National Institutes of Health

Tiffany Powell-Wiley, MD, MPH

Earl Stadtman Investigator, Chief of the Social Determinants of Obesity and Cardiovascular Risk Laboratory, National Institutes of Health

Tiffany M. Powell-Wiley MD, MPH is an Earl Stadtman Investigator and Chief of the Social Determinants of Obesity and Cardiovascular Risk Laboratory at the National Institutes of Health (NIH) with a joint appointment in the Cardiovascular Branch of the Division of Intramural Research at the National Heart, Lung, and Blood Institute (NHLBI) and the Intramural Research Program of the National Institute on Minority Health and Health Disparities. Dr. Powell-Wiley’s interdisciplinary team uses community-engaged research, epidemiologic methods, and translational approaches to better understand social factors that promote obesity and limit cardiovascular health. In 2021, Dr. Powell-Wiley’s innovative work was recognized with the American Heart Association’s Population Research Prize. In 2023, Dr. Powell-Wiley was chosen for the American Society for Clinical Investigation. In 2024, Dr. Powell-Wiley received the Presidential Medal of Distinction from The Obesity Society. At NIH, Dr. Powell-Wiley has mentored more than 50 research fellows at various career stages, several of whom are now tenure-track, NIH-funded faculty. Dr. Powell-Wiley serves as an Associate Editor for the Journal of the American Heart Association, as a Consulting Editor for Health Psychology, and is on the editorial board for the journal, Circulation. She has been recognized through NHLBI Director’s awards for developing a clinic in Washington, DC for community-engaged research, for mentorship of research fellows, and for promoting diversity in the biomedical workforce through mentorship efforts. Dr. Powell-Wiley graduated summa cum laude with a B.S.E. in chemical engineering from the University of Michigan in Ann Arbor. She received an MPH in Epidemiology from the University of North Carolina at Chapel Hill. She graduated with an MD from Duke University School of Medicine, where she was inducted into the Alpha Omega Alpha Medical Honor Society. Prior to joining NIH, Dr. Powell-Wiley completed internal medicine residency at Brigham and Women’s Hospital and cardiology fellowship at the University of Texas Southwestern Medical Center, where she served as the Cardiology Division’s first chief fellow.

Ariana M. Chao, PhD, CRNP, RN

Associate Professor, Johns Hopkins University School of Nursing

Ariana M. Chao, PhD, CRNP, RN

Associate Professor, Johns Hopkins University School of Nursing

Dr. Ariana M. Chao, PhD, CRNP, RN is an Associate Professor at the Johns Hopkins University School of Nursing with a joint appointment in the School of Medicine. She serves as the Director of Research at the Healthful Eating, Activity and Weight Program at Johns Hopkins where she also practices clinically as an obesity medicine nurse practitioner. She is internationally recognized for her leadership in obesity treatment. Her program of research is focused on the development of innovative treatments for obesity and related eating behaviors that improve physical and mental health. This includes creating and evaluating novel treatments for obesity, using biobehavioral approaches and considering social determinants of health to improve treatment access and efficacy. She has published over 100 articles. Her work has been supported by the National Institutes of Health as well as foundation and industry sponsors. Dr. Chao received her Bachelor and Master of Science in Nursing from Boston College, earned her PhD in nursing science at Yale University, and completed a postdoctoral fellowship at the University of Pennsylvania.

Sponsor

Support for this educational program has been provided by Novo Nordisk. SWHR maintains independence and editorial control over program development, content, and work products.